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deploy during surgery will not likely survive early vali-
dation. It must be easy to use.
One of the key advantages of hand-held suturing
devices is the ability to tailor each bite to the exact char-
acteristics of the graft and native vessel. An anastomot-
ic device must be appropriate for the diseased vessels
and for the exact angulation and layout of the surgical
field. Edges must be well coapted with proper sealing
and no impediment to flow. Most important, however,
as in all revascularization innovations, the device must
provide satisfactory long-term patency. Recent interest
in performing CABG through keyhole incisions has
intensified efforts to resolve the problem of how to per-
form coronary artery anastomoses through limited
access using endoscopic principles. Endoscopic micro-
suturing is extremely difficult. Indirect visualization via
a camera that replaces direct vision, coupled with the
use of rigid, long instruments, renders the results of
endoscopic suturing less than desirable. Ironically, very
sophisticated and expensive robotic technology has
been suggested to facilitate performance of endoscopic
anastomosis, but in a conventional suturing manner,1
rather than through alternative anastomotic concepts. It
is for this reason that robotic technology has failed so
far to simplify CABG.
Automated and semiautomated suturing devices are
now on the horizon.2 Also promising is technology that
shies away completely from traditional suturing. At
least eight medical technology companies are presently
focused on developing anastomotic devices to replace
conventional suturing for proximal and distal CABGs. 
Challenges confronting this “alternative anastomotic
technology” include success in three areas: delivery,
deployment, and durability.
In validating this new technology, surgeons have an
advantage over interventional cardiologists in the abili-
ty to access the chest cavity directly. This will likely
expedite the testing of some anastomotic devices, ini-
tially through open chest methods and without the lim-
itations of complex designs and material made to suit
endovascular access. Catheter-based endovascular
delivery, which should be the ultimate objective, will
necessitate the integration of imaging technology into
the operating rooms and the training of surgeons on
catheter-based techniques. Deployment of new anasto-
motic devices in more challenging and complex native
D uring the past 50 years and except for someattempts to use mechanical staplers by the Russian
pioneer surgeon Kolosov, almost all proximal and distal
aorta-coronary anastomoses have been done with con-
ventional hand-held sutures. The comfort to surgeons in
performing a reliable anastomosis with conventional
suturing has led to its adoption as the gold standard and
will likely be the principal reason for hesitancy in
adopting alternate anastomotic methods. So why
change?
Unquestionably, the principal impetus for change in
our cardiac surgical practice has been the desire to offer
patients less-invasive therapies, particularly in light of
the rapid growth of percutaneous catheter-based inter-
ventional cardiology procedures. Since 1995 and with
growing interest in developing platform technology for
minimally invasive coronary artery bypass grafting
(CABG), numerous concepts, devices, techniques, and
technologies have been introduced. Some have been
adopted. Others have vanished despite exhaustive
efforts by their industrial promoters. (Surgeons may
become excited quickly by new devices, but they also
have the intellectual and practical honesty to abandon
those that are of no benefit to their patients.) In fact, in
a review of all the instruments developed—including
cameras, scopes, retractors, occluders, and others—sta-
bilizers for coronary artery anastomosis stand alone as
the most significant contributors to the growth of beat-
ing-heart CABG. Of all the innovative technology to be
considered in the near future, anastomotic devices, in
my opinion, will have the greatest impact on the prac-
tice of CABG.
In general, for any anastomotic device to become
widely accepted, it must fulfill three essential charac-
teristics: facility, precision, and evidence of long-term
effectiveness. A device that is cumbersome to set and
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aortas and diseased coronary arteries will likely be the
Achilles’ heel of such devices for some time. Concern
with biocompatibility, thrombosis, and intimal prolifer-
ative response will necessitate long-term pre-marketing
studies for many of the devices.
In this issue of the Journal, Calafiore and colleagues3
present cutting-edge experience with a new anastomot-
ic device for performance of proximal CABGs. The
principle of the device is the deployment of a metal
connector mounted within a vascular conduit onto the
wall of the aorta. Like most coronary stents, the device
is made of inert metal with memory. It anchors the graft
to the wall of the aorta by recoiling to its original
design. Clinical experience from other companies with
different designs will be forthcoming. Nitinol stents are
only one category of devices that will soon become
available and commonplace in cardiac surgical prac-
tice. Other couplers, molds, and stents based on differ-
ent biocompatible material are currently being devel-
oped. Calafiore and associates have shown that it is
possible to implant one such anastomotic device with
reasonable facility and safety. Before stocking our
operating room shelves with it, however, we will need
more scientific validation on the safety, the efficacy,
and certainly the long-term angiographic follow-up of
anastomoses created with this device to confirm its
durability.
We also do not yet know whether these anastomotic
devices are practical in aortas with normal wall thick-
nesses only or for diseased aortic tissue of varying
thicknesses and densities. Furthermore, is this tech-
nique applicable to vein grafts of average diameter
only, or could it be used for smaller and larger veins?
What about arterial grafts? Will they sustain the shear
force of mounting and deploying the anastomotic
device? 
So what potential benefits to patients will this tech-
nology offer? 
First, this device allows the performance of a quality
anastomosis repeatedly, with consistency, and with
minimal intersurgeon variation. For the first time ever,
the coronary anastomosis will be determined not by the
skill of the surgeon but by the effectiveness of the
device. Second, the device is likely to expedite the pro-
cedure and allow several proximal anastomoses to be
done in very little time. Third, it represents yet another
facilitator for performing more off-pump beating-heart
CABGs. Perhaps the most significant potential advan-
tage of using this and other forthcoming proximal
aorta-coronary anastomotic devices is the likelihood of
less manipulation of the aorta, which will decrease the
risk of aortic embolic showering to the brain and other
organs.
What are the drawbacks?
The only one that I could think of, provided that this
technology will ultimately be applicable to all types
and sizes of vascular grafts, is the high cost. Assuming
$330 for a single application, another $1000 will be
added to a triple bypass operation. This is an untenable
price for CABG, a procedure already limited by other
economic restrains. However, by using this and other
facilitating technology, it may be possible to package a
new less-invasive CABG procedure with reduced oper-
ative and postoperative time and a lower risk of stroke.
As more devices are manufactured and used, the price
will be reduced.
CABG surgery will never be the same. The drive
toward new less-invasive strategies will assure not only
continuous improvement of surgical outcomes but also
an appreciation of the desire for patients to undergo
less onerous operations, competitive with current per-
cutaneous interventional cardiology procedures. As
long-term results of coronary stents continue to
improve, we as surgeons must respond by advocating
new and potentially less-invasive procedures that offer
the only remaining advantage for continuing CABG
today: long-term efficacy. 
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